ACADIA Pharmaceuticals Inc. (ACAD) Forms $22.31 Double Top; Profile of 3 Analysts Covering Best Buy Co., Inc. (BBY)

Best Buy Co., Inc. (NYSE:BBY) Logo

Among 11 analysts covering Best Buy Co (NYSE:BBY), 3 have Buy rating, 1 Sell and 7 Hold. Therefore 27% are positive. Best Buy Co had 16 analyst reports since August 29, 2018 according to SRatingsIntel. The firm has “Neutral” rating given on Wednesday, August 29 by JP Morgan. As per Wednesday, August 29, the company rating was maintained by Deutsche Bank. The rating was downgraded by Bank of America on Tuesday, November 13 to “Neutral”. The firm earned “Overweight” rating on Wednesday, November 21 by PiperJaffray. The company was maintained on Wednesday, November 21 by Telsey Advisory. On Monday, December 17 the stock rating was downgraded by Bank of America to “Underperform”. Morgan Stanley maintained the shares of BBY in report on Friday, November 23 with “Equal-Weight” rating. Raymond James maintained the stock with “Strong Buy” rating in Wednesday, August 29 report. The firm earned “Neutral” rating on Wednesday, November 21 by Wedbush. The stock has “Strong Buy” rating by Raymond James on Wednesday, November 21. See Best Buy Co., Inc. (NYSE:BBY) latest ratings:

17/12/2018 Broker: Bank of America Old Rating: Neutral New Rating: Underperform Old Target: $70 New Target: $50 Downgrade
27/11/2018 Broker: Loop Capital Markets Rating: Buy Maintain
21/11/2018 Broker: Telsey Advisory Rating: Hold Maintain
23/11/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $80 New Target: $75 Maintain
21/11/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $79 New Target: $72 Maintain
21/11/2018 Broker: Credit Suisse Old Rating: Neutral New Rating: Neutral Old Target: $78 New Target: $70 Maintain
21/11/2018 Broker: PiperJaffray Old Rating: Overweight New Rating: Overweight Old Target: $87 New Target: $81 Maintain
21/11/2018 Broker: Raymond James Old Rating: Strong Buy New Rating: Strong Buy Old Target: $90 New Target: $85 Maintain
21/11/2018 Broker: Wedbush Old Rating: Underperform New Rating: Neutral New Target: $65 Upgrade
13/11/2018 Broker: Bank of America Old Rating: Buy New Rating: Neutral Old Target: $92 New Target: $70 Downgrade

ACADIA Pharmaceuticals Inc. (ACAD) formed double top with $23.20 target or 4.00% above today’s $22.31 share price. ACADIA Pharmaceuticals Inc. (ACAD) has $3.20 billion valuation. The stock decreased 0.36% or $0.08 during the last trading session, reaching $22.31. About 727,523 shares traded. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 37.59% since February 14, 2018 and is downtrending. It has underperformed by 37.59% the S&P500. Some Historical ACAD News: 23/04/2018 – PMDAlliance and ACADIA Pharmaceuticals Survey Reveals Serious Quality-of-Life Impact of Non-Movement Symptoms of Parkinson’s; 09/05/2018 – Acadia Pharma Presenting at Bank of America Conference May 15; 27/04/2018 – ACADIA REAFFIRMS BENEFIT/RISK PROFILE OF NUPLAZID; 08/05/2018 – Acadia Pharma Presenting at Conference May 15; 27/04/2018 – ACADIA PHARM: 2 DATA SETS CONFIRM NUPLAZID IS WELL-TOLERATED; 04/05/2018 – ACADIA PHARMA 1Q LOSS/SHR 44C, EST. LOSS/SHR 56C; 26/03/2018 – Acadia Pharma Presenting at Conference Tomorrow; 02/05/2018 – ACADIA Pharmaceuticals Announces Appointment of Elena Ridloff, CFA, as Senior Vice President, Investor Relations; 04/05/2018 – ACADIA PHARMACEUTICALS INC – REITERATES 2018 NET SALES GUIDANCE OF $255 MLN TO $270 MLN; 26/04/2018 – STAT Plus: FDA could convene second advisory panel to re-examine safety of Acadia Pharma drug

Investors sentiment decreased to 0.92 in 2018 Q3. Its down 0.30, from 1.22 in 2018Q2. It dropped, as 31 investors sold ACADIA Pharmaceuticals Inc. shares while 45 reduced holdings. 31 funds opened positions while 39 raised stakes. 116.41 million shares or 1.85% more from 114.30 million shares in 2018Q2 were reported. 184,004 were accumulated by Wells Fargo And Mn. Moreover, Great West Life Assurance Can has 0% invested in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 11,789 shares. Glenmede Trust Na stated it has 4,055 shares. Tower Rech Lc (Trc) holds 0.06% or 42,230 shares. Lpl Financial Limited Company owns 130,768 shares. Great Lakes Advsr Ltd accumulated 213,973 shares. Opus Point Partners Mgmt stated it has 20,828 shares or 1.03% of all its holdings. Federated Investors Pa has invested 0% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). 140,000 are held by Weiss Multi. Morgan Stanley invested in 260,255 shares or 0% of the stock. Bnp Paribas Arbitrage Sa holds 0% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 48,299 shares. Jefferies Grp Inc Limited Liability Corp reported 0% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Moreover, Credit Agricole S A has 0% invested in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 2,500 shares. Comerica Natl Bank reported 0.01% stake. Proshare Advsrs Ltd Liability Co holds 0.01% or 66,460 shares.

Among 6 analysts covering ACADIA Pharmaceuticals (NASDAQ:ACAD), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. ACADIA Pharmaceuticals had 8 analyst reports since August 23, 2018 according to SRatingsIntel. The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has “Overweight” rating given on Tuesday, October 16 by Cantor Fitzgerald. The rating was upgraded by PiperJaffray on Friday, September 21 to “Overweight”. The firm has “Buy” rating given on Wednesday, October 10 by Bank of America. Cantor Fitzgerald maintained ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) rating on Thursday, November 1. Cantor Fitzgerald has “Overweight” rating and $30 target.

Since September 20, 2018, it had 2 insider buys, and 1 sale for $222.45 million activity. Brege Laura had sold 10,000 shares worth $200,041. BAKER BROS. ADVISORS LP had bought 1.21M shares worth $22.65M.

Analysts await ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to report earnings on February, 26. They expect $-0.56 earnings per share, down 1.82% or $0.01 from last year’s $-0.55 per share. After $-0.50 actual earnings per share reported by ACADIA Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 12.00% negative EPS growth.

The stock decreased 0.62% or $0.37 during the last trading session, reaching $59.49. About 3.00M shares traded. Best Buy Co., Inc. (NYSE:BBY) has declined 4.60% since February 14, 2018 and is downtrending. It has underperformed by 4.60% the S&P500. Some Historical BBY News: 27/03/2018 – Station Park Signs Best Buy to Open New Store in Farmington; 24/05/2018 – Best Buy’s Spending to Fight Amazon Comes at a Cost to Profit; 09/05/2018 – Amazon rolls out model ‘smart’ homes for U.S. shoppers to try out Alexa; 21/03/2018 – Best Buy Is Said to Sever Ties With Huawei on Security Concerns; 24/05/2018 – BEST BUY CO INC BBY.N CEO SAYS WILL BE ROLLING OUT MORE THAN 10 TV MODELS IN PARTNERSHIP WITH AMAZON BEGINNING JUNE THIS YEAR; 15/05/2018 – GREENLIGHT EXITED CC, JCP, VREX, KSS, BBY IN 1Q: 13F; 24/05/2018 – Best Buy Closes Below 50-Day Moving Average: Technicals; 22/03/2018 – Best Buy Appoints Richelle Parham to Best Buy Board of Directors; 27/03/2018 – Rep. Davis: Employees at CVS, Best Buy, & Starbucks All Seeing Benefits of Tax Reform; 18/04/2018 – Retail Rivals Amazon and Best Buy Team Up to Sell Smart TVs

Investors sentiment increased to 0.96 in Q3 2018. Its up 0.11, from 0.85 in 2018Q2. It improved, as 42 investors sold Best Buy Co., Inc. shares while 192 reduced holdings. 77 funds opened positions while 147 raised stakes. 213.03 million shares or 1.70% less from 216.72 million shares in 2018Q2 were reported. Euclidean Tech Limited Liability Corporation holds 1.29% in Best Buy Co., Inc. (NYSE:BBY) or 18,461 shares. Advsr Asset Mgmt Incorporated reported 0.07% in Best Buy Co., Inc. (NYSE:BBY). Cullen Frost Bankers Inc invested 0.01% of its portfolio in Best Buy Co., Inc. (NYSE:BBY). Guardian Life Of America invested in 686 shares or 0.01% of the stock. Teachers Retirement System Of The State Of Kentucky reported 229,245 shares stake. State Teachers Retirement Systems holds 0.08% or 453,658 shares in its portfolio. Jacobs Levy Equity has invested 0.44% in Best Buy Co., Inc. (NYSE:BBY). Contravisory Invest Mngmt has 0.16% invested in Best Buy Co., Inc. (NYSE:BBY). Nuwave Investment Lc holds 0.63% in Best Buy Co., Inc. (NYSE:BBY) or 5,312 shares. Ckw Fin Grp holds 0% of its portfolio in Best Buy Co., Inc. (NYSE:BBY) for 60 shares. Alpha Windward Limited Liability Company stated it has 0% of its portfolio in Best Buy Co., Inc. (NYSE:BBY). Moreover, Tiaa Cref Inv Management Limited Company has 0.07% invested in Best Buy Co., Inc. (NYSE:BBY) for 1.37M shares. 188,095 were accumulated by Fifth Third Financial Bank. Arrow Inv Advisors Ltd Liability Company has invested 0.29% of its portfolio in Best Buy Co., Inc. (NYSE:BBY). Kemnay Advisory Service has invested 0.4% in Best Buy Co., Inc. (NYSE:BBY).

More important recent Best Buy Co., Inc. (NYSE:BBY) news were published by: Seekingalpha.com which released: “Best Buy: A Retail Titan – Seeking Alpha” on February 01, 2019, also Benzinga.com published article titled: “Barron’s Picks And Pans: BB&T (NYSE:BBT), Best Buy (NYSE:BBY), Boeing (NYSE:BA) And More – Benzinga”, Benzinga.com published: “Barron’s On: The Most Sustainable Companies In America – Benzinga” on February 10, 2019. More interesting news about Best Buy Co., Inc. (NYSE:BBY) was released by: Seekingalpha.com and their article: “Online holiday sales up 17% in 2018 – Seeking Alpha” with publication date: January 15, 2019.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Institutional Positions Chart